A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

422

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

June 17, 2025

Study Completion Date

June 17, 2026

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

Sonelokimab

Sonelokimab

DRUG

Placebo

Placebo

Trial Locations (109)

1036

Clinical Site, Budapest

1407

Clinical Site, Sofia

1527

Clinical Site, Sofia

1606

Clinical Site, Sofia

4031

Clinical Site, Debrecen

4032

Clinical Site, Debrecen

5800

Clinical SIte, Pleven

7632

Clinical Site, Pécs

10012

Clinical Site, New York

10126

Clinical Site, Torino

10467

Clinical Site, The Bronx

10789

Clinical Site, Berlin

15831

Clinical Site, Mahlow

20089

Clinical Site, Rozzano

20122

Clinical Site, Milan

21614

Clinical Site, Buxtehude

24551

Clinical Site, Forest

25123

Clinical Site, Brescia

26133

Clinical Site, Oldenburg

29425

Clinical Site, Charleston

30159

Clinical Site, Hanover

30328

Clinical Site, Sandy Springs

31217

Clinical Site, Macon

33063

Clinical Site, Margate

33071

Clinical Site, Coral Springs

33134

Clinical Site, Coral Gables

33161

Clinical Site, Miami

33201

Clinical Site, Hollywood

33607

Clinical Site, Tampa

37215

Clinical Site, Nashville

40241

Clinical Site, Louisville

41124

Clinical Site, Modena

42283

Clinical Site, Wuppertal

44124

Clinical Site, Mayfield Heights

Clinical Site, Cona

44512

Clinical Site, Boardman

44805

Clinical Site, Bochum

45147

Clinical Site, Essen

45324

Clinical Site, Dayton

47150

Clinical Site, New Albany

47201

Clinical Site, Columbus

48088

Clinical Site, Warren

48126

Clinical Site, Dearborn

48149

Clinical Site, Münster

50125

Clinical Site, Florence

56126

Clinical Site, Pisa

60020

Clinical Site, Torrette

60118

Clinical Site, West Dundee

60590

Clinical Site, Frankfurt

66100

Clinical Site, Chieti

70006

Clinical Site, Metairie

73118

Clinical Site, Oklahoma City

75034

Clinical Site, Frisco

77004

Clinical Site, Houston

77082

Clinical Site, Houston

80131

Clinical Site, Napoli

80337

Clinical Site, München

84095

Clinical Site, South Jordan

89119

Clinical Site, Las Vegas

89129

Clinical Site, Langenau

90024

Clinical Site, Los Angeles

91054

Clinical Site, Erlangen

91325

Clinical Site, Northridge

92123

Clinical Site, San Diego

95123

Clinical Site, Catania

95815

Clinical Site, Sacramento

98012

Clinical Site, Mill Creek

02116

Clinical Site, Boston

02215

Clinical Site, Boston

T5J 3S9

Clinical Site, Edmonton

T6H 4J8

Clinical Site, Edmonton

T8H 0P1

Clinical Site, Sherwood Park

R3M 3Z4

Clinical Site, Winnipeg

E3B 1G9

Clinical Site, Fredericton

L4M 7G1

Clinical Site, Barrie

N6H 5L5

Clinical Site, London

L3P 1X3

Clinical Site, Markham

L3Y 5G8

Clinical Site, Newmarket

M2N 3A6

Clinical Site, Toronto

M5A3R6

Clinical Site, Toronto

H1Y 3L1

Clinical Site, Montreal

G1W 4R4

Clinical Site, Québec

J1G 1X9

Clinical Site, Sherbrooke

06108

Clinical SIte, Halle

06129

Clinical Site, Perugia

00168

Clinical Site, Rome

0372

Clinical Site, Oslo

15-453

Clinical Site, Bialystok

80-214

Clinical Site, Gdansk

30-002

Clinical Site, Krakow

30-727

Clinical Site, Krakow

90-265

Clinical Site, Lodz

90-436

Clinical Site, Lodz

20-573

Clinical Site, Lublin

42-624

Clinical Site, Ossy

60-529

Clinical Site, Poznan

41-200

Clinical Site, Sosnowiec

71-500

Clinical Site, Szczecin

00-710

Clinical Site, Warsaw

02-507

Clinical Site, Warsaw

02-692

Clinical Site, Warsaw

51-503

Clinical Site, Wroclaw

1169-050

Clinical Site, Lisbon

1649-035

Clinical Site, Lisbon

4050-342

Clinical Site, Porto

CF14 4XW

Clinical Site, Cardiff

DY1 2HQ

Clinical Site, Dudley

LS9 7TF

Clinical Site, Leeds

M6 8HD

Clinical Site, Salford

Sponsors
All Listed Sponsors
lead

MoonLake Immunotherapeutics AG

INDUSTRY

NCT06411899 - A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa | Biotech Hunter | Biotech Hunter